NASDAQ:MGLN - Magellan Health Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $67.19 -1.26 (-1.84 %) (As of 05/23/2019 04:00 PM ET)Previous Close$68.45Today's Range$66.69 - $67.8752-Week Range$51.88 - $99.90Volume237,299 shsAverage Volume301,227 shsMarket Capitalization$1.62 billionP/E Ratio27.54Dividend YieldN/ABeta0.5 ProfileAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Magellan Health, Inc. provides healthcare management services in the United States. The company operates in Healthcare and Pharmacy Management segments. The Healthcare segment offers carve-out management services for behavioral health; employee assistance plans (EAP); and other areas of specialty healthcare, including diagnostic imaging, musculoskeletal management, cardiac, and physical medicine. It also contracts with state Medicaid agencies, and the centers for Medicare and Medicaid services to manage care for beneficiaries under Medicaid and Medicare programs, such as healthcare and long-term support services through its network of medical and behavioral health professionals, clinics, hospitals, nursing facilities, home care agencies, and ancillary service providers. The Pharmacy Management segment comprises products and solutions that provide clinical and financial management of pharmaceuticals paid under medical and pharmacy benefit programs. It offers pharmacy benefit management services, such as pharmaceutical dispensing services; pharmacy benefit administration for state Medicaid and other government sponsored programs; clinical and formulary management programs; medical pharmacy management programs; and programs for the integrated management of specialty drugs that treat complex conditions. The company provides services to health plans and other managed care organizations, employers, labor unions, various military and governmental agencies, and third party administrators. Magellan Health, Inc. was founded in 1969 and is headquartered in Scottsdale, Arizona. Receive MGLN News and Ratings via Email Sign-up to receive the latest news and ratings for MGLN and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Hospitals Sub-IndustryManaged Health Care SectorMedical Current SymbolNASDAQ:MGLN Previous Symbol CUSIP55907920 CIK19411 Webhttp://www.magellanhealth.com/ Phone602-572-6050Debt Debt-to-Equity Ratio0.56 Current Ratio1.67 Quick Ratio1.62Price-To-Earnings Trailing P/E Ratio27.54 Forward P/E Ratio24.17 P/E Growth1.34 Sales & Book Value Annual Sales$7.31 billion Price / Sales0.22 Cash Flow$7.8401 per share Price / Cash Flow8.57 Book Value$53.79 per share Price / Book1.25Profitability EPS (Most Recent Fiscal Year)$2.44 Net Income$24.18 million Net Margins0.18% Return on Equity3.83% Return on Assets1.64%Miscellaneous Employees10,500 Outstanding Shares24,044,000Market Cap$1.62 billion Next Earnings Date7/26/2019 (Estimated) OptionableOptionable Magellan Health (NASDAQ:MGLN) Frequently Asked Questions What is Magellan Health's stock symbol? Magellan Health trades on the NASDAQ under the ticker symbol "MGLN." How were Magellan Health's earnings last quarter? Magellan Health Inc (NASDAQ:MGLN) issued its quarterly earnings data on Thursday, May, 2nd. The company reported $0.40 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.34 by $0.06. The business had revenue of $1.74 billion for the quarter, compared to analysts' expectations of $1.75 billion. Magellan Health had a return on equity of 3.83% and a net margin of 0.18%. The company's revenue for the quarter was down 3.6% on a year-over-year basis. During the same period in the prior year, the firm earned $0.81 EPS. View Magellan Health's Earnings History. When is Magellan Health's next earnings date? Magellan Health is scheduled to release their next quarterly earnings announcement on Friday, July 26th 2019. View Earnings Estimates for Magellan Health. What guidance has Magellan Health issued on next quarter's earnings? Magellan Health issued an update on its FY19 earnings guidance on Thursday, May, 2nd. The company provided EPS guidance of $3.70-4.69 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.92. The company issued revenue guidance of $7.0-7.2 billion, compared to the consensus revenue estimate of $7.22 billion. What price target have analysts set for MGLN? 4 brokers have issued 12-month target prices for Magellan Health's shares. Their forecasts range from $68.00 to $84.00. On average, they expect Magellan Health's share price to reach $73.50 in the next year. This suggests a possible upside of 9.4% from the stock's current price. View Analyst Price Targets for Magellan Health. What is the consensus analysts' recommendation for Magellan Health? 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Magellan Health in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Magellan Health. Has Magellan Health been receiving favorable news coverage? Media coverage about MGLN stock has trended somewhat negative recently, according to InfoTrie Sentiment. InfoTrie identifies negative and positive news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Magellan Health earned a daily sentiment score of -1.7 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the stock's share price in the near future. Who are some of Magellan Health's key competitors? Some companies that are related to Magellan Health include Encompass Health (EHC), Healthscope (HSO), MEDNAX (MD), Select Medical (SEM), Primary Health Care (PRY), Medical Facilities (DR), Capitol Health (CAJ), Animalcare Group (ANCR), SunLink Health Systems (SSY), Spine Injury Solutions (SPIN) and THC Biomed Intl (THC). What other stocks do shareholders of Magellan Health own? Based on aggregate information from My MarketBeat watchlists, some companies that other Magellan Health investors own include Energy Transfer LP Unit (ET), Netflix (NFLX), Ford Motor (F), CBL & Associates Properties (CBL), ConocoPhillips (COP), Edwards Lifesciences (EW), UnitedHealth Group (UNH), Cornerstone Total Return Fund (CRF), Abeona Therapeutics (ABEO) and Cypress Semiconductor (CY). Who are Magellan Health's key executives? Magellan Health's management team includes the folowing people: Mr. Barry Morgan Smith, Chairman, CEO & CEO of Magellan Healthcare (Age 65)Mr. Jonathan Neal Rubin, Chief Financial Officer (Age 55)Mr. Daniel Norman Gregoire, Gen. Counsel & Sec. (Age 63)Mr. Mostafa M. Kamal, Chief Exec. Officer of Magellan Rx Management (Age 38)Ms. Renie Shapiro Silver, SVP - Corp. Fin. Who are Magellan Health's major shareholders? Magellan Health's stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (14.58%), Dimensional Fund Advisors LP (8.40%), Victory Capital Management Inc. (3.04%), Northern Trust Corp (3.02%), Renaissance Technologies LLC (2.87%) and Geode Capital Management LLC (1.33%). Company insiders that own Magellan Health stock include Barry M Smith, Clapper Caskie Lewis, Daniel N Gregoire, Jeffrey N West, Jonathan N Rubin and Mostafa Kamal. View Institutional Ownership Trends for Magellan Health. Which major investors are selling Magellan Health stock? MGLN stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Morgan Stanley, LSV Asset Management, BlackRock Inc., Kennedy Capital Management Inc., Man Group plc, Victory Capital Management Inc. and Dimensional Fund Advisors LP. View Insider Buying and Selling for Magellan Health. Which major investors are buying Magellan Health stock? MGLN stock was purchased by a variety of institutional investors in the last quarter, including 13D Management LLC, 13D Management LLC, Parametric Portfolio Associates LLC, Assenagon Asset Management S.A., FMR LLC, Jacobs Levy Equity Management Inc., JPMorgan Chase & Co. and Geode Capital Management LLC. View Insider Buying and Selling for Magellan Health. How do I buy shares of Magellan Health? Shares of MGLN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Magellan Health's stock price today? One share of MGLN stock can currently be purchased for approximately $67.19. How big of a company is Magellan Health? Magellan Health has a market capitalization of $1.62 billion and generates $7.31 billion in revenue each year. The company earns $24.18 million in net income (profit) each year or $2.44 on an earnings per share basis. Magellan Health employs 10,500 workers across the globe. What is Magellan Health's official website? The official website for Magellan Health is http://www.magellanhealth.com/. How can I contact Magellan Health? Magellan Health's mailing address is 4800 SCOTTSDALE ROAD, SCOTTSDALE AZ, 85251. The company can be reached via phone at 602-572-6050 or via email at [email protected] MarketBeat Community Rating for Magellan Health (NASDAQ MGLN)Community Ranking: 2.5 out of 5 ( )Outperform Votes: 300 (Vote Outperform)Underperform Votes: 306 (Vote Underperform)Total Votes: 606MarketBeat's community ratings are surveys of what our community members think about Magellan Health and other stocks. Vote "Outperform" if you believe MGLN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MGLN will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/23/2019 by MarketBeat.com StaffFeatured Article: How does a security become overbought? Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.